David E Overcashier

Title: **David E. Overcashier: Innovator in Protein Formulation**

Introduction

David E. Overcashier, based in Montara, California, is a distinguished inventor with a notable portfolio of six patents. His work focuses primarily on advancements in protein formulation, demonstrating significant contributions to biopharmaceutical innovation.

Latest Patents

Among his latest patents, David has developed a stable lyophilized protein formulation that can be reconstituted with a suitable diluent. This formulation achieves a high protein concentration that is suitable for subcutaneous administration. Notably, he has prepared formulations for anti-IgE and anti-HER2 antibodies through lyophilization, utilizing a lyoprotectant to maintain stability. This innovative approach allows the lyophilized mixture to be reconstituted into a high protein concentration without significant loss of stability.

Career Highlights

David is currently employed at Genentech, Inc., a leading biotechnology company recognized for its pioneering contributions to medical advancements. His inventive spirit and dedication to research have significantly influenced the company's capabilities in the pharmaceutical industry.

Collaborations

Collaboration plays a crucial role in David's work, as he has partnered with esteemed colleagues like Jeffrey L. Cleland and Chung C. Hsu. Their combined efforts in research and development help drive innovation and enhance the effectiveness of protein-based therapies.

Conclusion

David E. Overcashier exemplifies the spirit of innovation within the biopharmaceutical field. His contributions in protein formulation have the potential to transform treatment protocols and improve patient outcomes. With his ongoing work at Genentech, Inc. and his collaborations, he continues to pave the way for future advancements in medicine.